Clinical significance of anti-cyclic citrullinated peptide antibodies in patients with juvenile rheumatoid arthritis

Clinical significance of anti-cyclic citrullinated peptide antibodies in patients with juvenile rheumatoid arthritis

Bibliographic Details
Main Authors:	Bo Li, Zhizho Ye, Fenlia Guo, Jianso Li
Format:	Article
Language:	English
Published:	BMC 2008-09-01
Series:	Pediatric Rheumatology Online Journal

Similar Items

Bone mineral density in patients with Juvenile Rheumatoid Arthritis
by: Zhizho Ye, et al.
Published: (2008-09-01)

Antibodies to cyclic citrullinized peptide in rheumatoid arthritis
by: E N Aleksandrova, et al.
Published: (2004-12-01)

Anti-cyclic citrullinated peptide antibodies in children with Juvenile Idiopathic Arthritis
by: Mohamed Hamooda, et al.
Published: (2016-09-01)

Evaluation of Anti-Mutated Citrullinated Vimentin Antibodies, Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Omani Patients with Rheumatoid Arthritis
by: Ahmed Al-Shukaili, et al.
Published: (2012-01-01)

Anti-cyclic citrullinated peptide antibody predicts the development of rheumatoid arthritis in patients with undifferentiated arthritis
by: Chun Li, et al.
Published: (2019-12-01)

RHEUMATOID FACTOR AND ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN PATIENTS WITH PSORIATIC ARTHRITIS
by: V. V. Badokin, et al.
Published: (2011-06-01)

Ocular manifestations of rheumatoid arthritis and their correlation with anti-cyclic citrullinated peptide antibodies
by: Vignesh AP, et al.
Published: (2015-02-01)

Pathogenic Role of Circulating Citrullinated Antigens and Anti-Cyclic Monoclonal Citrullinated Peptide Antibodies in Rheumatoid Arthritis
by: Pureun Won, et al.
Published: (2021-06-01)

Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis
by: Tebo Anne E, et al.
Published: (2012-08-01)

Frequency and diagnostic significance of anti-cyclic citrullinated peptide antibodies (ACCP) and anti-modified citrullinated vimentin antibodies (AMCV) in children with early juvenile arthritis
by: S O Salugina, et al.
Published: (2008-12-01)

Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis
by: Theodoridou Katerina, et al.
Published: (2007-04-01)

Diagnostic utility of Anti-cyclic Citrullinated Peptide Antibodies for Very Early Rheumatoid Arthritis
by: Sucilathangam G, et al.
Published: (2014-07-01)

Diagnostic and prognostic value of antibodies to cyclic citrullinated peptide (Anti-CCP) in rheumatoid arthritis
by: G.L. Erre, et al.
Published: (2004-06-01)

Anti-Cyclic Citrullinated Peptide Antibody-Positive Meningoencephalitis in the Preclinical Period of Rheumatoid Arthritis
by: Tomoya Shibahara, et al.
Published: (2016-07-01)

The diagnostic value of anti-cyclic citrullinated peptide antibodies (anti-CCP) in patients with rheumatoid arthritis
by: Damjanovska Ljubinka, et al.
Published: (2007-01-01)

Anti-cyclic citrullinated Peptide antibody is associated with interstitial lung disease in patients with rheumatoid arthritis.
by: Yufeng Yin, et al.
Published: (2014-01-01)

Anti-Cyclic Citrullinated Peptide Antibodies and Severity of Interstitial Lung Disease in Women with Rheumatoid Arthritis
by: Alberto Daniel Rocha-Muñoz, et al.
Published: (2015-01-01)

Meta-Analysis: Diagnostic Accuracy of Anti-Cyclic Citrullinated Peptide Antibody for Juvenile Idiopathic Arthritis
by: Yan Wang, et al.
Published: (2015-01-01)

Rheumatoid factor versus anti - cyclic citrullinated peptide antibody as screening tool for rheumatoid arthritis in an ophthalmic clinic
by: Prabhakar Singh, et al.
Published: (2020-01-01)

Diagnostic value of anti-cyclic citrullinated peptide antibody combined with rheumatoid factor in rheumatoid arthritis in Asia: a meta-analysis
by: Xiaochun Yang, et al.
Published: (2021-09-01)

Serum Levels of Anti-Cyclic Citrullinated Peptide Antibodies in Patients with Sjögren Syndrome Accompanied by Rheumatoid Arthritis
by: Toshiaki Kogure, et al.
Published: (2009-01-01)

Usefulness of anti-cyclic citrullinate peptide antibody determination in synovial fluid analysis of patients with rheumatoid arthritis
by: G. Valesini, et al.
Published: (2011-09-01)

Effect of anti - cyclic citrullinated peptide antibody and Rheumatoid factor on clinical diseases activity index in patients with rheumatoid arthritis
by: Jafarzadeh L, et al.
Published: (2015-09-01)

Erosive arthritis and anti-cyclic citrullinated peptide antibodies in systemic sclerosis
by: A Abdessemed, et al.
Published: (2017-01-01)

Identification of natural bispecific antibodies against cyclic citrullinated peptide and immunoglobulin G in rheumatoid arthritis.
by: Wei Wang, et al.
Published: (2011-01-01)

Diagnostic value of different anti-citrullinated peptides antibodies in rheumatoid arthritis
by: Ruiz-Ortiz de Arrizabaleta Estíbaliz, et al.
Published: (2011-11-01)

The prevalence and diagnostic performance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: The predictive and discriminative ability of serum antibody level in recognizing rheumatoid arthritis
by: Heidari Behzad, et al.
Published: (2009-01-01)

Onset of polyarticular juvenile idiopathic arthritis with both anti-cyclic citrullinated peptide antibodies and rheumatoid factor in a 3-year-old girl
by: Yasui Kozo, et al.
Published: (2012-12-01)

Anti-cyclic citrullinated peptide antibodies – a role in rheumatoid arthritis and the possibility of seroconversion: A focus on abatacept
by: N. V. Chichasova
Published: (2017-03-01)

The relationship between the presence of anti-cyclic citrullinated peptide antibodies and clinical phenotype in very early rheumatoid arthritis
by: Cader Mohammed Z, et al.
Published: (2010-08-01)

The study of tempromandibular joint disorders and anti-cyclic citrullinated peptide antibodies in serum and saliva of patients with rheumatoid arthritis
by: Raya M Khidhir, et al.
Published: (2014-01-01)

Antibodies to citrullinated alpha-enolase peptide in rheumatoid arthritis
by: Fisher, Benjamin Alexis Charles
Published: (2010)

Study on the Molecular Basis of Anti-Citrullinated Peptide Antibodies in the Immunopathogenesis of Rheumatoid Arthritis
by: Ming-Chi Lu, et al.
Published: (2010)

Evaluation of anti-mutated citrullinated vimentin antibodies, anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis in comparison with other rheumatic diseases; a nephrology point of view
by: Alireza Sadeghi, et al.
Published: (2017-04-01)

The Contribution of Serum Anti–cyclic Citrullinated Peptide Antibody and Matrix Metalloproteinase-3 in Predicting the Activity of Rheumatoid Arthritis Disease
by: Aida R. Al-Derzi
Published: (2017-07-01)

Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement
by: S.L.E. Ribeiro, et al.
Published: (2008-11-01)

Assessment of anti-cyclic citrullinated peptide in psoriatic arthritis
by: Galal Zenab A, et al.
Published: (2009-03-01)

Anti-Cyclic Citrullinated Peptide (Anti-CCP) and Anti-Mutated Citrullinated Vimentin (Anti-MCV) Relation with Extra-Articular Manifestations in Rheumatoid Arthritis
by: Laura Gonzalez-Lopez, et al.
Published: (2014-01-01)

Anti-cyclic citrullinated peptide: its prevalence and clinical significance in a South African cohort with juvenile idiopathic arthritis
by: Mistry BJ, et al.
Published: (2008-09-01)

Specificity of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis
by: Nicole H. Trier, et al.
Published: (2019-06-01)